Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Product Briefs

This article was originally published in The Gray Sheet

Executive Summary

FDA approves St. Jude's Brio deep brain stimulator for Parkinson's and essential tremor. The agency also approves Aesculap's activL artificial disc and said Cerapedics' i-Factor bone graft review will proceed without an advisory panel.

You may also be interested in...



Cervical Spine Bone Graft Gains FDA Go-Ahead

Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.

St. Jude Reveals Path For AF Ablation Catheter: 3-Year Study Begins Soon

St. Jude Medical will begin enrollment by July for a pivotal study of its Cool Path Duo/Safire BLU Duo irrigated radiofrequency energy-based catheter ablation system for treatment of atrial fibrillation, the firm said during its Feb. 5 annual investor day

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Related Companies

UsernamePublicRestriction

Register

MT033983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel